日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Activity of Human NK Cells Towards 3D Heterotypic Cellular Tumor Model of Breast Cancer.

人类NK细胞对乳腺癌3D异型细胞肿瘤模型的活性

Leonteva Anastasia, Abdurakhmanova Maria, Bogachek Maria, Belovezhets Tatyana, Yurina Anna, Troitskaya Olga, Kulemzin Sergey, Richter Vladimir, Kuligina Elena, Nushtaeva Anna

A potent, broadly neutralizing human monoclonal antibody that efficiently protects hACE2-transgenic mice from infection with the Wuhan, BA.5, and XBB.1.5 SARS-CoV-2 variants

一种强效、广谱中和的人类单克隆抗体,可有效保护hACE2转基因小鼠免受武汉、BA.5和XBB.1.5 SARS-CoV-2变种的感染。

Guselnikov, Sergey V; Baranov, Konstantin O; Kulemzin, Sergey V; Belovezhets, Tatyana N; Chikaev, Anton N; Murasheva, Svetlana V; Volkova, Olga Y; Mechetina, Ludmila V; Najakshin, Alexander M; Chikaev, Nikolai A; Solodkov, Pavel P; Sergeeva, Maria V; Smirnov, Alexander V; Serova, Irina A; Serov, Oleg L; Markhaev, Alexander G; Kononova, Yulia V; Alekseev, Alexander Y; Gulyaeva, Marina A; Danilenko, Daria M; Battulin, Nariman R; Shestopalov, Alexander M; Taranin, Alexander V

Serial Llama Immunization with Various SARS-CoV-2 RBD Variants Induces Broad Spectrum Virus-Neutralizing Nanobodies

使用各种 SARS-CoV-2 RBD 变体对骆驼进行连续免疫可诱导广谱病毒中和纳米抗体

Pavel P Solodkov, Alexander M Najakshin, Nikolai A Chikaev, Sergey V Kulemzin, Ludmila V Mechetina, Konstantin O Baranov, Sergey V Guselnikov, Andrey A Gorchakov, Tatyana N Belovezhets, Anton N Chikaev, Olga Y Volkova, Alexander G Markhaev, Yulia V Kononova, Alexander Y Alekseev, Marina A Gulyaeva, 

Hybrid Immunity from Gam-COVID-Vac Vaccination and Natural SARS-CoV-2 Infection Confers Broader Neutralizing Activity against Omicron Lineage VOCs Than Revaccination or Reinfection

与再接种疫苗或再感染相比,Gam-COVID-Vac 疫苗接种和自然 SARS-CoV-2 感染产生的混合免疫力对 Omicron 谱系 VOC 具有更广泛的中和活性

Sergey V Kulemzin, Sergey V Guselnikov, Boris G Nekrasov, Svetlana V Molodykh, Irina N Kuvshinova, Svetlana V Murasheva, Tatyana N Belovezhets, Andrey A Gorchakov, Anton N Chikaev, Nikolai A Chikaev, Olga Y Volkova, Anna A Yurina, Alexander M Najakshin, Alexander V Taranin

Comparative Pre-Clinical Analysis of CD20-Specific CAR T Cells Encompassing 1F5-, Leu16-, and 2F2-Based Antigen-Recognition Moieties

包含基于 1F5、Leu16 和 2F2 的抗原识别部分的 CD20 特异性 CAR T 细胞的比较临床前分析

Tatyana Belovezhets, Sergey Kulemzin, Olga Volkova, Alexander Najakshin, Alexander Taranin, Andrey Gorchakov

Memory B Cells Induced by Sputnik V Vaccination Produce SARS-CoV-2 Neutralizing Antibodies Upon Ex Vivo Restimulation

接种 Sputnik V 疫苗后诱导产生的记忆 B 细胞在体外再次刺激后可产生 SARS-CoV-2 中和抗体

Maria G Byazrova ,Sergey V Kulemzin ,Ekaterina A Astakhova ,Tatyana N Belovezhets ,Grigory A Efimov ,Anton N Chikaev ,Ilya O Kolotygin ,Andrey A Gorchakov ,Alexander V Taranin ,Alexander V Filatov

Functional Profiling of In Vitro Reactivated Memory B Cells Following Natural SARS-CoV-2 Infection and Gam-COVID-Vac Vaccination

自然感染 SARS-CoV-2 和接种 Gam-COVID-Vac 疫苗后体外再激活记忆 B 细胞的功能分析

Ekaterina A Astakhova, Maria G Byazrova, Gaukhar M Yusubalieva, Sergey V Kulemzin, Natalia A Kruglova, Alexey G Prilipov, Vladimir P Baklaushev, Andrey A Gorchakov, Alexander V Taranin, Alexander V Filatov

VH3-53/66-Class RBD-Specific Human Monoclonal Antibody iB20 Displays Cross-Neutralizing Activity against Emerging SARS-CoV-2 Lineages

VH3-53/66 类 RBD 特异性人单克隆抗体 iB20 显示出针对新出现的 SARS-CoV-2 谱系的交叉中和活性

Sergey V Kulemzin, Maria V Sergeeva, Konstantin O Baranov, Andrey A Gorchakov, Sergey V Guselnikov, Tatyana N Belovezhets, Olga Yu Volkova, Alexander M Najakshin, Nikolai A Chikaev, Daria M Danilenko, Alexander V Taranin

Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern

分离出一组可中和 SARS-CoV-2 及其相关病毒变体的超强人类抗体

Andrey A Gorchakov #, Sergey V Kulemzin #, Sergey V Guselnikov #, Konstantin O Baranov #, Tatyana N Belovezhets, Ludmila V Mechetina, Olga Yu Volkova, Alexander M Najakshin, Nikolai A Chikaev, Anton N Chikaev, Pavel P Solodkov, Victor F Larichev, Marina A Gulyaeva, Alexander G Markhaev, Yulia V Kono

Strategies to Circumvent the Side-Effects of Immunotherapy Using Allogeneic CAR-T Cells and Boost Its Efficacy: Results of Recent Clinical Trials

利用同种异体CAR-T细胞免疫疗法规避副作用并提高疗效的策略:近期临床试验结果

Smirnov, Sergei; Petukhov, Alexey; Levchuk, Ksenia; Kulemzin, Sergey; Staliarova, Alena; Lepik, Kirill; Shuvalov, Oleg; Zaritskey, Andrey; Daks, Alexandra; Fedorova, Olga